Trials / Unknown
UnknownNCT04198402
Microbiotic Analysis in Digestive Endocrine Tumors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Incidence of digestive neuroendocrine tumors are increasing. Analysis of individual microbiota is a way to explore new neoplastic mechanisms, tumor identification and therapeutic orientations. This prospective pilot study aims to describe fecal bacterial phylogeny of patients with digestive neuroendocrine tumor. Bacterial genomic signature will be recorded at initiation of Lanreotide treatment in naive patient with digestive neuroendocrine tumor (pancreas or small intestine), metastatic or locally advanced, as well as after one year follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Biological sampling | Blood sample (5mL) for metabolomic dosage and Fecal sample for ARN16s sequencing |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2022-01-01
- Completion
- 2023-01-01
- First posted
- 2019-12-13
- Last updated
- 2019-12-13
Source: ClinicalTrials.gov record NCT04198402. Inclusion in this directory is not an endorsement.